Roche Asks Court To Declare Enzo Patent Invalid
The lawsuit, filed in the U.S. District Court for the Southern District of New York, seeks declaratory judgment of patent invalidity with respect to Enzo's 4,994,373 patent. The patent covers labeling of polymerase chain reaction (PCR) products, widely used by medical and law enforcement officials.
The complaint also asks the court to declare that Roche did not breach its...
To view the full article, register now.